Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALADIN: Long-acting Somatostatin in ADPKD
NCT00309283Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Apr 2006
- Primary completion
- Jan 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of octreotide in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Mario Negri Institute for Pharmacological Research. Started Apr 2006; status: completed.
02
Drugs
octreotide
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT00309283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309283.